Overcoming cancer therapeutic bottleneck by drug repurposing | Signal Transduction and Targeted Therapy
IJMS | Free Full-Text | Mechanisms of Multidrug Resistance in Cancer Chemotherapy | HTML
Oncology and Cancer Therapeutics Journals | Oncology Research Journals
Clinical Cancer Research - Wikipedia
Oncology and Cancer Therapeutics Journals | Oncology Research Journals
Overcoming cancer therapeutic bottleneck by drug repurposing | Signal Transduction and Targeted Therapy
Clinical Cancer Drugs
Drug resistance and combating drug resistance in cancer
.jpg "Anti-Cancer Drugs")
Anti-Cancer Drugs
The high price of anticancer drugs: origins, implications, barriers, solutions | Nature Reviews Clinical Oncology
The State of Cancer Care in America, 2017: A Report by the American Society of Clinical Oncology | JCO Oncology Practice
Overcoming cancer therapeutic bottleneck by drug repurposing | Signal Transduction and Targeted Therapy
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions - eClinicalMedicine
Frontiers | PLGA-Based Nanoparticles in Cancer Treatment | Pharmacology
Americans Can't Keep Up with High Cost of Cancer Treatment
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13 | The BMJ
Home Page ::: Current Cancer Drug Targets
Risks and benefits of anticancer drugs in advanced cancer patients: A systematic review and meta-analysis - eClinicalMedicine
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Understanding Pharmacogenomics | Cancer.Net
Investigating the Side Effects of Cancer Immunotherapy - NCI
Frontiers | Navigating Multi-Scale Cancer Systems Biology Towards Model-Driven Clinical Oncology and Its Applications in Personalized Therapeutics | Oncology
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received | Journal of Clinical Oncology
